chrX:154517825:> Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chrX:153,746,149-153,775,787 |
| hg38 | chrX:154,517,825-154,547,572 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
| <0.001 | cerebral infarction | NA | BeFree | Detail | |
| 0.080 | Transient ischemic attack | NA | RGD | Detail | |
| <0.001 | cholelithiasis | NA | BeFree | Detail | |
| 0.080 | cholestasis | NA | BeFree,RGD | Detail | |
| <0.001 | hemophilia B | NA | BeFree | Detail | |
| <0.001 | Colonic Neoplasms | NA | BeFree | Detail | |
| 0.002 | Coronary heart disease | NA | GAD | Detail | |
| 0.080 | congenital hypothyroidism | NA | RGD | Detail | |
| 0.080 | Multi-infarct dementia | NA | RGD | Detail | |
| 0.120 | contact dermatitis | NA | CTD_human | Detail | |
| 0.001 | Diabetes | NA | BeFree | Detail | |
| 0.001 | diabetes mellitus | NA | BeFree | Detail | |
| 0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
| 0.003 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD | Detail | |
| <0.001 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
| 0.080 | Diabetic Nephropathy | NA | BeFree,RGD | Detail | |
| <0.001 | Muscular Dystrophy, Duchenne | NA | BeFree | Detail | |
| 0.003 | Elliptocytosis, Hereditary | NA | BeFree,GAD | Detail | |
| 0.002 | encephalitis | NA | GAD | Detail | |
| <0.001 | Enterovirus Infections | NA | BeFree | Detail | |
| <0.001 | Esophageal Neoplasms | NA | BeFree | Detail | |
| <0.001 | Exanthema | NA | BeFree | Detail | |
| 0.131 | favism | Glucose-6-phosphate dehydrogenase Mediterranean mutation is one of the most comm... | BeFree,CTD_human,GAD | 25339475 | Detail |
| <0.001 | fragile X syndrome | NA | BeFree | Detail | |
| <0.001 | Gardner syndrome | NA | BeFree | Detail | |
| 0.001 | Gilbert Disease (disorder) | NA | BeFree | Detail | |
| 0.007 | Glycogen Storage Disease Type I | NA | GAD | Detail | |
| 0.120 | chronic granulomatous disease | NA | BeFree,CTD_human | Detail | |
| <0.001 | cardiac arrest | NA | BeFree | Detail | |
| <0.001 | Heart failure | NA | BeFree | Detail | |
| <0.001 | congestive heart failure | NA | BeFree | Detail | |
| 0.004 | Hemoglobinopathies | Glucose-6-phosphate dehydrogenase (G6PD) deficiency and hemoglobinopathies were ... | BeFree,GAD | 25915902 | Detail |
| 0.003 | hemoglobinuria | NA | BeFree,GAD | Detail | |
| 0.129 | Hemolysis (disorder) | NA | CTD_human,GAD | Detail | |
| <0.001 | Hemophilia A | NA | BeFree | Detail | |
| 0.080 | hepatic encephalopathy | NA | RGD | Detail | |
| <0.001 | hepatitis B | NA | BeFree | Detail | |
| <0.001 | Hepatolenticular Degeneration | NA | BeFree | Detail | |
| <0.001 | HIV Infections | NA | BeFree | Detail | |
| <0.001 | Hyperaldosteronism | NA | BeFree | Detail | |
| 0.025 | Hyperbilirubinemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Hyperbilirubinemia, Hereditary | NA | GAD | Detail | |
| 0.080 | Hypercholesterolemia | NA | RGD | Detail | |
| <0.001 | pulmonary hypertension | Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation... | BeFree | 25480333 | Detail |
| 0.080 | Hypertension, Renovascular | NA | RGD | Detail | |
| 0.080 | Hypertriglyceridemia | NA | RGD | Detail | |
| <0.001 | Immunologic Deficiency Syndromes | NA | BeFree | Detail | |
| <0.001 | Bloch Sulzberger syndrome | NA | BeFree | Detail | |
| 0.080 | Insulin resistance | NA | RGD | Detail | |
| 0.011 | neonatal jaundice | NA | BeFree,GAD | Detail | |
| 0.002 | kernicterus | Misdiagnosis of G-6-PD deficiency in neonates, at risk of severe hemolytic episo... | BeFree | 25632835 | Detail |
| 0.080 | Kidney Diseases | NA | RGD | Detail | |
| <0.001 | Leishmaniasis, Cutaneous | NA | BeFree | Detail | |
| <0.001 | Infection by Leishmania braziliensis | NA | BeFree | Detail | |
| 0.002 | leukemia | NA | BeFree | Detail | |
| <0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Acute Erythroblastic Leukemia | NA | BeFree | Detail | |
| <0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Acute Megakaryocytic Leukemias | NA | BeFree | Detail | |
| 0.002 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| 0.004 | Myeloid Leukemia, Chronic | NA | BeFree | Detail | |
| <0.001 | Leukemia, Myeloid, Chronic-Phase | NA | BeFree | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| 0.002 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
| 0.028 | malaria | Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malar... | BeFree,GAD | 25015414 | Detail |
| 0.028 | malaria | Plasmodium vivax radical cure requires the use of primaquine (PQ), a drug that i... | BeFree,GAD | 25141282 | Detail |
| 0.028 | malaria | In response to high frequency of malaria infection, several host genetic factors... | BeFree,GAD | 25172454 | Detail |
| 0.028 | malaria | G6PD deficient subgroup had a marginally increased risk of malaria infection com... | BeFree,GAD | 25470251 | Detail |
| 0.028 | malaria | Blood samples for G6PD fluorescent spot test (FST), G6PD genotyping, and malaria... | BeFree,GAD | 25536053 | Detail |
| 0.028 | malaria | The use of primaquine and other 8-aminoquinolines for malaria elimination is ham... | BeFree,GAD | 25646252 | Detail |
| 0.028 | malaria | African glucose-6-phosphate dehydrogenase alleles associated with protection fro... | BeFree,GAD | 25671784 | Detail |
| 0.028 | malaria | G6PD gene variants and its association with malaria in a Sri Lankan population. | BeFree,GAD | 25885177 | Detail |
| 0.028 | malaria | Polymorphisms of G6PD did not significantly influence the prevalence malaria (P ... | BeFree,GAD | 26448013 | Detail |
| 0.023 | Malaria, Falciparum | Glucose-6-phosphate dehydrogenase (G6PD) enzyme function and genotype were deter... | BeFree,GAD | 24913169 | Detail |
| 0.003 | Malaria, Vivax | NA | BeFree,GAD | Detail | |
| <0.001 | melanoma | NA | BeFree | Detail | |
| 0.001 | Mental Retardation | NA | BeFree | Detail | |
| <0.001 | Metabolic Diseases | NA | BeFree | Detail | |
| <0.001 | Inborn errors of metabolism | NA | BeFree | Detail | |
| <0.001 | methemoglobinemia | NA | BeFree | Detail | |
| <0.001 | multiple myeloma | NA | BeFree | Detail | |
| <0.001 | myopathy | NA | BeFree | Detail | |
| <0.001 | muscular dystrophy | NA | BeFree | Detail | |
| <0.001 | Myeloproliferative disease | NA | BeFree | Detail | |
| 0.080 | myocardial infarction | NA | RGD | Detail | |
| <0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
| <0.001 | neurofibromatosis 1 | NA | BeFree | Detail | |
| 0.080 | obesity | NA | BeFree,RGD | Detail | |
| <0.001 | oculocerebrorenal syndrome | NA | BeFree | Detail | |
| <0.001 | pancytopenia | NA | BeFree | Detail | |
| 0.120 | phagocyte bactericidal dysfunction | NA | CTD_human | Detail | |
| 0.080 | Phenylketonurias | NA | RGD | Detail | |
| <0.001 | polycythemia | NA | BeFree | Detail | |
| <0.001 | polycythemia vera | NA | BeFree | Detail | |
| <0.001 | polyps | NA | BeFree | Detail | |
| <0.001 | Preleukemia | NA | BeFree | Detail | |
| <0.001 | priapism | NA | BeFree | Detail | |
| 0.080 | Reperfusion Injury | NA | RGD | Detail | |
| <0.001 | Age-related cataract | NA | BeFree | Detail | |
| <0.001 | Septicemia | NA | BeFree | Detail | |
| 0.007 | Sickle Cell Trait | NA | BeFree,GAD | Detail | |
| 0.001 | hereditary spherocytosis | NA | BeFree | Detail | |
| 0.003 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
| 0.002 | thalassemia | NA | BeFree | Detail | |
| <0.001 | Thrombocythemia, Essential | NA | BeFree | Detail | |
| <0.001 | Upper Respiratory Infections | NA | BeFree | Detail | |
| <0.001 | Virus Diseases | NA | BeFree | Detail | |
| <0.001 | Vitamin A Deficiency | NA | BeFree | Detail | |
| <0.001 | Vitamin B 12 Deficiency | NA | BeFree | Detail | |
| <0.001 | Wiskott-Aldrich syndrome | NA | BeFree | Detail | |
| 0.082 | cataract | NA | BeFree,RGD | Detail | |
| 0.243 | Deficiency of glucose-6-phosphate dehydrogenase | In the present investigation, DNA samples from 17 patients with G6PD deficiency ... | BeFree | 9891846 | Detail |
| <0.001 | esophageal carcinoma | NA | BeFree | Detail | |
| <0.001 | Color Blindness, Red-Green | NA | BeFree | Detail | |
| <0.001 | nephrogenic diabetes insipidus | NA | BeFree | Detail | |
| <0.001 | Neurofibromatoses | NA | BeFree | Detail | |
| <0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | neurofibrosarcoma | NA | BeFree | Detail | |
| <0.001 | Red blood cell disorder | NA | BeFree | Detail | |
| <0.001 | Sickle cell-beta-thalassemia | NA | BeFree | Detail | |
| <0.001 | Premature aging syndrome | NA | BeFree | Detail | |
| <0.001 | Anemia, severe | G6PD A- heterozygotes and hemizygotes/homozygotes experienced dose-dependent low... | BeFree | 24913169 | Detail |
| <0.001 | Anemia, severe | By logistic regression, three clinical variables predicted G6PD status: maternal... | BeFree | 26240158 | Detail |
| 0.001 | color blindness | NA | BeFree | Detail | |
| <0.001 | Sepsis | NA | BeFree | Detail | |
| <0.001 | Multiple tumors | NA | BeFree | Detail | |
| <0.001 | parathyroid adenoma | NA | BeFree | Detail | |
| <0.001 | Unconjugated hyperbilirubinemia | NA | BeFree | Detail | |
| 0.080 | Porphobilinogen synthase deficiency | NA | RGD | Detail | |
| <0.001 | Impaired glucose tolerance | NA | BeFree | Detail | |
| <0.001 | Drug-induced hemolytic anemia | NA | BeFree | Detail | |
| <0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
| <0.001 | Philadelphia chromosome positive chronic myelogenous leukemia | NA | BeFree | Detail | |
| <0.001 | Philadelphia chromosome negative chronic myelogenous leukemia | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of esophagus | Glucose-6-phosphate dehydrogenase expression is correlated with poor clinical pr... | BeFree | 26329784 | Detail |
| <0.001 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree | Detail | |
| <0.001 | Congenital color blindness | NA | BeFree | Detail | |
| <0.001 | Deficiency of pyruvate kinase | In response to high frequency of malaria infection, several host genetic factors... | BeFree | 25172454 | Detail |
| <0.001 | Uridine monophosphate hydrolase deficiency | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
| <0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
| 0.080 | Non-alcoholic Fatty Liver Disease | NA | RGD | Detail | |
| <0.001 | Fragile X chromosome | NA | BeFree | Detail | |
| 0.005 | Chronic non-spherocytic hemolytic anemia | NA | BeFree,GAD | Detail | |
| <0.001 | Respiratory distress | NA | BeFree | Detail | |
| 0.006 | Enzymopathy | NA | BeFree | Detail | |
| <0.001 | Bilateral cataracts (disorder) | NA | BeFree | Detail | |
| 0.080 | Metabolic syndrome X | NA | RGD | Detail | |
| <0.001 | Malignant neoplasm of esophagus | NA | BeFree | Detail | |
| 0.001 | Cardiovascular Diseases | Some examples include the alanine-to-valine substitution at codon 222 (Ala222--&... | BeFree | 11916749 | Detail |
| 0.145 | Anemia, Hemolytic | Some examples include the alanine-to-valine substitution at codon 222 (Ala222--&... | BeFree | 11916749 | Detail |
| 0.131 | favism | Some examples include the alanine-to-valine substitution at codon 222 (Ala222--&... | BeFree | 11916749 | Detail |
| <0.001 | Chronic anemia | NA | BeFree | Detail | |
| <0.001 | Carcinogenesis | NA | BeFree | Detail | |
| <0.001 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | Furthermore, high G6PD expression was tightly associated with histological grade... | BeFree | 26329784 | Detail |
| <0.001 | Thalassemia trait | NA | BeFree | Detail | |
| <0.001 | malignant peripheral nerve sheath tumor | NA | BeFree | Detail | |
| <0.001 | Spots on skin | NA | BeFree | Detail | |
| <0.001 | hereditary anemia | NA | BeFree | Detail | |
| 0.010 | Hyperbilirubinemia, Neonatal | NA | BeFree,GAD | Detail | |
| <0.001 | Plasmodium vivax infection | NA | BeFree | Detail | |
| 0.080 | Drug-Induced Liver Injury | NA | RGD | Detail | |
| <0.001 | Beta thalassemia trait | NA | BeFree | Detail | |
| <0.001 | Cardiomyopathies | NA | BeFree | Detail | |
| <0.001 | Cholestasis in newborn | NA | BeFree | Detail | |
| <0.001 | Mental Retardation, X-Linked | NA | BeFree | Detail | |
| <0.001 | Degenerative disorder | Moreover, how G6PD status alters the susceptibility of the affected individuals ... | BeFree | 24720642 | Detail |
| <0.001 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | NA | BeFree | Detail | |
| 0.005 | Chronic hemolytic anemia | NA | BeFree | Detail | |
| 0.001 | alpha^+^ Thalassemia | NA | BeFree | Detail | |
| <0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| <0.001 | Erythrocytosis | NA | BeFree | Detail | |
| <0.001 | Slow acetylator due to N-acetyltransferase enzyme variant | NA | BeFree | Detail | |
| <0.001 | 6-Phosphogluconolactonase Deficiency | NA | BeFree | Detail | |
| <0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree | Detail | |
| 0.081 | liver carcinoma | NA | BeFree,RGD | Detail | |
| 0.120 | Acute kidney injury | NA | CTD_human | Detail | |
| <0.001 | SPHEROCYTOSIS, TYPE 1 (disorder) | NA | BeFree | Detail | |
| <0.001 | Incontinentia pigmenti, familial male-lethal type | NA | BeFree | Detail | |
| 0.243 | Deficiency of glucose-6-phosphate dehydrogenase | Glucose-6-phosphate dehydrogenase (G6PD) enzyme function and genotype were deter... | BeFree,CTD_human,GAD,LHGDN | 24913169 | Detail |
| 0.243 | Deficiency of glucose-6-phosphate dehydrogenase | Glucose-6-phosphate dehydrogenase deficiency is an X-linked recessive hereditary... | BeFree,CTD_human,GAD,LHGDN | 24943486 | Detail |
| 0.243 | Deficiency of glucose-6-phosphate dehydrogenase | It has been documented that G6PD deficiency in sub-Saharan Africa is due to the ... | BeFree,CTD_human,GAD,LHGDN | 25015414 | Detail |
| 0.243 | Deficiency of glucose-6-phosphate dehydrogenase | The G6PD A- mutation (G202A and A376G) does not appear to have a role in G6PD de... | BeFree,CTD_human,GAD,LHGDN | 25169987 | Detail |
| 0.243 | Deficiency of glucose-6-phosphate dehydrogenase | Glucose-6-phosphate dehydrogenase Mediterranean mutation is one of the most comm... | BeFree,CTD_human,GAD,LHGDN | 25339475 | Detail |
| 0.243 | Deficiency of glucose-6-phosphate dehydrogenase | Also, G-6-PD activity varies among female heterozygous neonates, and G-6-PD muta... | BeFree,CTD_human,GAD,LHGDN | 25632835 | Detail |
| 0.243 | Deficiency of glucose-6-phosphate dehydrogenase | Haplotype analysis reveals the G6PD locus to be under balancing selection, sugge... | BeFree,CTD_human,GAD,LHGDN | 25671784 | Detail |
| 0.243 | Deficiency of glucose-6-phosphate dehydrogenase | We developed a PCR-reverse dot blot (RDB) assay to screen twenty genotypes of se... | BeFree,CTD_human,GAD,LHGDN | 25775246 | Detail |
| 0.080 | Homocysteinemia | NA | RGD | Detail | |
| 0.003 | Infection | NA | LHGDN | Detail | |
| 0.013 | alpha-Thalassemia | NA | BeFree,GAD | Detail | |
| 0.012 | anemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.145 | Anemia, Hemolytic | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| 0.004 | Anemia, Hemolytic, Congenital | NA | BeFree,LHGDN | Detail | |
| 0.123 | Anemia, Hemolytic, Congenital Nonspherocytic | NA | BeFree,CTD_human | Detail | |
| 0.017 | Anemia, Sickle Cell | NA | BeFree,GAD | Detail | |
| <0.001 | Fabry disease | NA | BeFree | Detail | |
| <0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
| <0.001 | Bacteremia | NA | BeFree | Detail | |
| 0.007 | beta thalassemia | NA | BeFree,GAD | Detail | |
| <0.001 | bipolar disorder | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of breast | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glucose-6-phosphate dehydrogenase Mediterranean mutation is one of the most common mutations causing... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glucose-6-phosphate dehydrogenase (G6PD) deficiency and hemoglobinopathies were the inherited condit... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Misdiagnosis of G-6-PD deficiency in neonates, at risk of severe hemolytic episodes, extreme hyperbi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fula... | DisGeNET | Detail |
| Plasmodium vivax radical cure requires the use of primaquine (PQ), a drug that induces haemolysis in... | DisGeNET | Detail |
| In response to high frequency of malaria infection, several host genetic factors have been selected,... | DisGeNET | Detail |
| G6PD deficient subgroup had a marginally increased risk of malaria infection compared to the G6PD no... | DisGeNET | Detail |
| Blood samples for G6PD fluorescent spot test (FST), G6PD genotyping, and malaria testing were taken ... | DisGeNET | Detail |
| The use of primaquine and other 8-aminoquinolines for malaria elimination is hampered by, among othe... | DisGeNET | Detail |
| African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in ... | DisGeNET | Detail |
| G6PD gene variants and its association with malaria in a Sri Lankan population. | DisGeNET | Detail |
| Polymorphisms of G6PD did not significantly influence the prevalence malaria (P > 0.05). | DisGeNET | Detail |
| Glucose-6-phosphate dehydrogenase (G6PD) enzyme function and genotype were determined in Ugandan chi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In the present investigation, DNA samples from 17 patients with G6PD deficiency from Tianjin area in... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| G6PD A- heterozygotes and hemizygotes/homozygotes experienced dose-dependent lower hemoglobin concen... | DisGeNET | Detail |
| By logistic regression, three clinical variables predicted G6PD status: maternal country of birth (P... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glucose-6-phosphate dehydrogenase expression is correlated with poor clinical prognosis in esophagea... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In response to high frequency of malaria infection, several host genetic factors have been selected,... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Some examples include the alanine-to-valine substitution at codon 222 (Ala222-->Val) [DNA: C-to-T... | DisGeNET | Detail |
| Some examples include the alanine-to-valine substitution at codon 222 (Ala222-->Val) [DNA: C-to-T... | DisGeNET | Detail |
| Some examples include the alanine-to-valine substitution at codon 222 (Ala222-->Val) [DNA: C-to-T... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Furthermore, high G6PD expression was tightly associated with histological grade, TNM staging and ly... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Moreover, how G6PD status alters the susceptibility of the affected individuals to certain degenerat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glucose-6-phosphate dehydrogenase (G6PD) enzyme function and genotype were determined in Ugandan chi... | DisGeNET | Detail |
| Glucose-6-phosphate dehydrogenase deficiency is an X-linked recessive hereditary disease characteris... | DisGeNET | Detail |
| It has been documented that G6PD deficiency in sub-Saharan Africa is due to the 202A/376G G6PD A-all... | DisGeNET | Detail |
| The G6PD A- mutation (G202A and A376G) does not appear to have a role in G6PD deficiency in a Saudi ... | DisGeNET | Detail |
| Glucose-6-phosphate dehydrogenase Mediterranean mutation is one of the most common mutations causing... | DisGeNET | Detail |
| Also, G-6-PD activity varies among female heterozygous neonates, and G-6-PD mutation analysis provid... | DisGeNET | Detail |
| Haplotype analysis reveals the G6PD locus to be under balancing selection, suggesting a mechanism of... | DisGeNET | Detail |
| We developed a PCR-reverse dot blot (RDB) assay to screen twenty genotypes of seventeen Chinese G6PD... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386545618 dbSNP
- Genome
- hg38
- Position
- chrX:154,517,825-154,547,572
- Variant Type
- snv
Genome browser